Gene mutation of thiopurine s-methyltransferase in uygur chinese

被引:14
|
作者
Zhang, JP
Guan, YY
Xu, AL
Zhou, SF
Wu, JH
Wei, H
Huang, M
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Pharmacol, Guangzhou 510089, Peoples R China
[3] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510080, Peoples R China
[4] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore
关键词
thiopurine; S-methyltransferase; gene mutation;
D O I
10.1007/s00228-004-0730-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. This study was to investigate the gene mutation of thiopurine S-methyltransferase (TPMT) in Uygur Chinese. Methods. Polymerase chain reaction-based methods were used to analyze three commonly reported inactivating mutations-G238C, G460A and A719G. Results. One TPMT*3A heterozygote and five TPMT*3C heterozygotes were found in 160 Uygur Chinese subjects, and allele frequencies of TPMT*3A and TPMT*3C were 0.3% and 1.6%, respectively. Conclusion. TPMT*3C is a common mutant allele in Uygur Chinese, while TPMT*3A is a rare mutant allele in Uygur Chinese.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [21] The Importance of Thiopurine S-Methyltransferase Gene Analysis Before Azathioprine Therapy
    Gurbuz, Gurkan
    Edizer, Selvinaz
    Yilmaz, Unsal
    Unalp, Aycan
    CLINICAL NEUROPHARMACOLOGY, 2020, 43 (04) : 112 - 113
  • [22] Genetic polymorphism of thiopurine S-methyltransferase in Argentina
    Laróvere, LE
    de Kremer, RD
    Lambooy, LHJ
    De Abreu, RA
    ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 : 388 - 393
  • [23] Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus
    Relling, MV
    Hancock, ML
    Rivera, GK
    Sandlund, JT
    Ribeiro, RC
    Krynetski, EY
    Pui, CH
    Evans, WE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23): : 2001 - 2008
  • [24] Thiopurine S-methyltransferase as a target for drug interactions
    Xin, HW
    Fischer, C
    Schwab, M
    Klotz, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) : 395 - 398
  • [25] Influence of Mesalazine on Thiopurine S-Methyltransferase Activity
    Outeda-Macias, M.
    Salvador-Garrido, P.
    Martinez-Lopez, L. M.
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 729 - 730
  • [26] Insights into the biological role of thiopurine S-methyltransferase
    Urbancic, D.
    Smid, A.
    Kanduser, M.
    Kotar, A.
    Plavec, J.
    Mlinaric-Rascan, I.
    FEBS OPEN BIO, 2021, 11 : 40 - 41
  • [27] Molecular diagnosis of thiopurine S-methyltransferase deficiency
    Blank, RD
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (11) : 1041 - 1041
  • [28] Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese
    Zhang, JP
    Zhou, SF
    Chen, X
    Huang, M
    CLINICA CHIMICA ACTA, 2006, 365 (1-2) : 337 - 341
  • [29] Methylation of selenocysteine catalysed by thiopurine S-methyltransferase
    Urbancic, Dunja
    Kotar, Anita
    Smid, Alenka
    Jukic, Marko
    Gobec, Stanislav
    Martensson, Lars-Goran
    Plavec, Janez
    Mlinaric-Rascan, Irena
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2019, 1863 (01): : 182 - 190
  • [30] Thiopurine S-methyltransferase as a target for drug interactions
    Hua-Wen Xin
    Christine Fischer
    Matthias Schwab
    Ulrich Klotz
    European Journal of Clinical Pharmacology, 2005, 61 : 395 - 398